Tag: Adam Falconi

Time for a Change? Fraser Institute Urges Canada to Strengthen its Pharmaceutical IP Laws

A little over a week ago, the Fraser Institute, a prominent and independent Canadian public policy think tank, released a report calling for a strengthening

July 24, 2013 No Comments

Sitting This One Out: SCC Refuses to Clarify “Promise of a Patent” Doctrine

Last month, the Supreme Court of Canada (SCC) denied leave to appeal in the case Eli Lilly Canada Inc v Novopharm Ltd, passing on an

June 4, 2013 No Comments

A Cautionary Kudos: Canada Moves Up on USTR IP Watch List

Earlier this month, the United States Trade Representative (USTR) released its annual “Special 301 Report,” which evaluates the intellectual property rights (IPR) protection and enforcement

May 21, 2013 No Comments

Tag: Adam Falconi

Time for a Change? Fraser Institute Urges Canada to Strengthen its Pharmaceutical IP Laws

Sitting This One Out: SCC Refuses to Clarify “Promise of a Patent” Doctrine

A Cautionary Kudos: Canada Moves Up on USTR IP Watch List

Search

Categories

Newsletter